BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Clin Oncol. Jun 24, 2026; 17(6): 117812
Published online Jun 24, 2026. doi: 10.5306/wjco.117812
Figure 1
Figure 1 Flowchart of patient selection and inclusion. A total of 240 patients with adrenal cavernous hemangioma treated between 2003 and 2023 were screened, and 102 hypertensive adrenal cavernous hemangioma patients meeting the imaging, pathological and follow-up eligibility criteria were included in the final analysis. ACH: Adrenal cavernous hemangioma; RAAS: Renin-angiotensin-aldosterone system; ROC: Receiver operating characteristic.

  • Citation: Du ZG, Wu YY, Homyy T, Zhao WQ, Minsler T, Tekosiv S, Zhang T, Song C, Tui TL, Shi ST, Tan HJ, Jan S, Deng SJ, Qiu LM, Su TX, Teisy S, Zhuang ZX, Xie XJ, Qiu TX, Xiong ZD, Lang TX, Zhen XL, Qin JX, Zheng XB, Teriguezs X, Fie T, Hasly G, Duan CK, Deng CH. Factors influencing postoperative of hypertension remission in adrenal cavernous hemangioma: A multicenter retrospective cohort study. World J Clin Oncol 2026; 17(6): 117812
  • URL: https://www.wjgnet.com/2218-4333/full/v17/i6/117812.htm
  • DOI: https://dx.doi.org/10.5306/wjco.117812

Write to the Help Desk